Dramamine, Nix Drive Prestige Consumer Sales

 
• By Malcolm Spicer

Consumers’ OTC drug choices extend beyond pain relievers, heartburn remedies and allergy formulations, Prestige Consumer Healthcare points out as it announces reported revenues up 0.8% to $279.3m in its latest quarter.

Prestige Consumer highlights its advertising over the years for Dramamine: 2018 and 2020, top left to right, and 2021 and 2023, bottom. • Source: Source: Prestige Consumer Healthcare

More from Archive

More from HBW Insight